References
- European Pharmacopeia. Strasbourg, France: Council of Europe; 2010
- Cremer K. Orally disintegrating dosage forms provide life cycle management opportunities. Pharm Technol 2003;27:22–9
- Camarco W, Ray D, Druffner A. Selecting superdisintegrants for orally disintegrating tablet formulations. Pharm Technol 2006;30:28–37
- Yamamoto Y, Fujii M, Watanabe K, et al. Effect of powder characteristics on oral tablet disintegration. Int J Pharm 2009;365:116–20
- Late SG, Yu Y, Banga AK. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegranting tablets. Int J Pharm 2009;365:4–11
- He X, Barone M, Marsac PJ, Sperry DC. Development of a rapidly dispersing tablet of a poorly wettable compound-formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib. Int J Pharm 2008;353:176–86
- Viscasillas A, Fernandez F, del Pozo A, Calpena AC. Pharmaceutical design of a new lactose-free coprocessed excipient: application of hydrochlorothiazide as a low solubility drug model. Drug Dev Ind Pharm, on line May 2012; 1–9. DOI: 10.3109/03639045.2012.686507
- Parakh SR, Gothosakar AV. A review of mouth dissolving tablet technologies. Pharm Technol 2003;27:92–100
- Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Biopharm 2002;15:295–305
- Mahmoud AA, Salah S. Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets. Drug Dev Ind Pharm 2012;38:762–9
- Tan Q, Zhang L, Liu G, et al. Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation. Drug Dev Ind Pharm, on line September 2012; 1–8. DOI: 10.3109/03639045.2012.718784
- Suñé-Negre JM, Roig-Carreras M, Fuster-Garcia R, et al. Nueva metodología de preformulación galénica para la caracterización de sustancias en relación a su viabilidad para la compresión: Diagrama SeDeM. Cien Technol Pharm 2005;3:125–36
- García-Montoya E, Suñé-Negre JM, Roig-Carreras M, et al. Characterization of powders to preformulation studies with a new expert system (SeDeM Diagram). Poster in the 6th World meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona; 7–10 April 2008
- García-Montoya E, Suñé-Negre JM, Pérez-Lozano P, et al. Metodología de preformulación galénica para la caracterización de sustancias en relación a su viabilidad para la compresión: diagrama SeDeM. Farmaespaña Industrial 2010;33:58–62
- Pérez-Lozano P, Suñé-Negre JM, Roig-Carreras M, et al. A new expert systems (SeDeM Diagram) for control batch powder formulation and preformulation drug products. Eur J Pharm Biopharm 2006; 64:351–9
- Aguilar-Díaz JE, García-Montoya E, Suñé-Negre JM, et al. Characterization of disintegrants and diluents with a new experimental system (SeDeM Index & Diagram) for preformulation purposes. Poster in the 6th World meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona; 7–10 April 2008
- Suñé-Negre JM, Roig-Carreras M, Fuster-Garcia R, et al. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation. Eur J Pharm Biopharm 2008;69:1029–39
- Aguilar-Díaz JE, García-Montoya E, Suñé-Negre JM, et al. The use of the SeDeM Diagram expert system to determine the suitability of diluents–disintegrants for direct compression and their use in formulation of ODT. Eur J Pharm Biopharm 2009;73:414–23
- Aguilar-Díaz JE, García-Montoya E, Suñé-Negre JM, et al. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. Eur J Pharm Biopharm 2012;80:638–48
- Suñé-Negre JM, Roig-Carreras M, Fuster-Garcia R, et al. Optimization of parameters of the SeDeM Diagram Expert System: Hausner index (IH) and relative humidity (%RH). Eur J Pharm Biopharm 2011;79:464–72
- Suñé-Negre JM, Roig-Carreras M, Fuster-Garcia R, et al. SeDeM diagram: a new expert system for the formula. In: Vizureanu P, ed. Expert systems for human, materials and automation. Rijeka (Croacia): Intech Open Access Publisher; 2011:17–34
- Font Quer P. Medicamenta, 6th ed. Barcelona: Editorial Labor; 1962
- European Pharmacopeia, 7th ed., vol. 7.2. Strasbourg, France: Council of Europe; 2011, 04/2011: 20901
- The United States Pharmacopeia (USP 32 NF-27), 31 revision. Rockville (MD): United States Pharmacopeial Convention Inc.; 2009; <USP Monographs:701 > Page 266
- Rubinstein MH. Pharmaceutical technology (tabletting technology), 1st ed. Madrid: SA de Ediciones; 1993
- Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical Press; 2006
- Casadio S. Tecnologia farmaceutica. 2nd ed. Milan: Cisalpino-Goliardica; 1972
- Helman, J. Farmacotecnia teórica y práctica. Méjico: Compañía Internacional Continental; 1981
- U.S. Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research (CDER) Guidance for Industry: Orally disintegrating tablets: FDA. Dec 2008. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070578.pdf [last accessed Nov 2011]
- The United States Pharmacopeia (USP 32 NF-27), 32st revision. Rockville (MD): United States Pharmacopeial Convention Inc.; 2009; <USP Monographs:711>
- Wong LW, Pilpel N. The effect of particle shape on the mechanical properties of powders. Int J Pharm 1990; 59:145–54
- Braidotti L, Bulgarelli, D. Tecnica farmaceutica. 1st ed. Milan: Lleditrice Scientifica LG Guadagni; 1974